STEPHEN SIU: Open Payments
NPI 1831732577 · NEW HYDE PARK, NY. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$787 in 23 payments from 11 companies in 2025. Trend: 2023 $0 · 2024 $0 · 2025 $787
Food & beverage: $787
| Company | Payments | Amount |
|---|---|---|
| Galderma Laboratories, L.P. | 1 | $150 |
| ABBVIE INC. | 5 | $145 |
| Incyte Corporation | 5 | $122 |
| Novartis Pharmaceuticals Corporation | 2 | $82 |
| LEO Pharma Inc. | 2 | $60 |
| UCB, Inc. | 2 | $59 |
| GENZYME CORPORATION | 1 | $55 |
| E.R. Squibb & Sons, L.L.C. | 2 | $42 |
| Janssen Biotech, Inc. | 1 | $27 |
| SUN PHARMACEUTICAL INDUSTRIES INC. | 1 | $23 |
Products named: NEMLUVIO, SKYRIZI, OPZELURA, ANZUPGO, Bimzelx, DUPIXENT, Sotyktu, COSENTYX.
Industry payments across NY — which companies pay providers there.
